Introduction
The infectious bacterium P. aeruginosa secretes a protective exopolysaccharide called alginate that forms a viscous capsule around the organism. This alginate coating is believed to contribute to the bacteria's widespread resistance to antibiotics and its ability to evade the host's immune response (Govan & Deretic, 1996) . Chronic P. aeruginosa infections are the leading cause of morbidity and mortality in cystic ®brosis patients (Govan & Deretic, 1996) and are also common in cancer, burn and immunocompromised patients. Because of alginate's role in the pathogenicity of P. aeruginosa, enzymes in the alginate biosynthetic pathway are attractive candidates for clinical inhibitors.
Pseudomonad alginate is a linear polymer of (1±4)-linked -d-mannuronate and -l-guluronate residues. Many of the mannuronate residues are O-acetylated at the 2-or 3-position or both. The alginate biosynthetic pathway as it is currently understood is shown in Fig. 1 . PMM/PGM is encoded by the algC gene and catalyzes the conversion of mannose 6-phosphate to mannose 1-phosphate in the second step of the alginate biosynthetic pathway. It is also required for A-band lipopolysaccharide biosynthesis, where it utilizes glucose 6-phosphate as a substrate. These dual biosynthetic roles for PMM/PGM were con®rmed by algC mutants that lacked the alginate phenotype and O-side chain and core lipopolysaccharides (Ye et al., 1994) . PMM/ PGM has a molecular weight of 50 200 Da and is reported to be a monomer in solution (Ye et al., 1994) . It requires Mg 2+ for maximal activity and is activated by glucose-1,6-bisphosphate. The reaction is believed to proceed through a phosphoenzyme intermediate at Ser108 (Shankar et al., 1995) .
P. aeruginosa PMM/PGM shows only moderate sequence identity (30±50%) with other bacterial phosphomannomutases and phosphoglucomutases and very little homology with the rabbit muscle PGM which has been structurally characterized by Ray et al. (1993) . P. aeruginosa PMM/PGM also differs from rabbit muscle PGM in a number of its functional characteristics, including its substrate speci®city and metal-ion preference (Ye et al., 1994) .
Materials and methods
The algC gene was ampli®ed from P. aeruginosa strain PAO1 by the polymerase chain reaction using primers based on the published sequence. The forward primer incorporated an NdeI site and the reverse primer incorporated a BamHI site, so the amplicon could be cloned directly into the pET3-a (Novagen) vector. The resulting construct was used to transform BL21(DE3) cells. Freshly transformed cells were grown to an optical density at 600 nm of $0.6 and expression of the algC gene was induced by the addition of IPTG to a ®nal Biosynthetic pathway of alginate in P. aeruginosa. Several key enzymes are indicated: PMI-GMP, phosphomannose isomerase-GDP pyrophosphorylase; PMM/PGM, phosphomannomutase/phosphoglucomutase; GMD, GDP-mannose dehydrogenase; ME, mannuronan epimerase. Genes encoding each enzyme are indicated in italics.
crystallization papers concentration of 0.4 mM. Cells were harvested 4±5 h after induction and stored at 195 K until use. PMM/PGM was puri®ed to homogeneity following the published procedure (Ye et al., 1994) . Approximately 200 mg of puri®ed protein was obtained from 17 g of frozen cell paste. MALDI massspectrometric analysis (Mass Consortium, La Jolla, CA, USA) of the puri®ed PMM/ PGM indicates two predominant species differing by approximately 77 Da, consistent with isolation of both phospho and dephospho forms of the enzyme (a phosphoryl group is 79 Da).
Initial crystallization screens employed conditions found in the Hampton Research Crystal Screen kits 1 and 2. The PMM/PGM solution was at 12±15 mg ml À1 in 10 mM MOPS buffer pH 7.0. Crystals grow by hanging-drop vapor diffusion from 1.4 M sodium/potassium tartrate and 100 mM Na HEPES pH 7.5 from drops containing 2 ml of protein and 2 ml of well buffer. Crystals grow from heavy precipitate in drops; de novo growth time varies widely from two weeks to four months. Use of micro-and macroseeding techniques has reliably produced crystals within several weeks. A solution of 40% glycerol and 1.4 M sodium/potassium tartrate was used to cryoprotect the PMM/PGM crystals for low-temperature data collection. Crystals were transferred gradually into solutions of increasing glycerol concentration and were¯ash-frozen in a nitrogen stream for data collection.
To facilitate structure solution, a selenomethionine (SeMet) substituted PMM/PGM (eight methionine residues) was produced in Escherichia coli by growing bacteria in minimal media and in the presence of SeMet and lysine, threonine, phenylalanine, leucine, isoleucine and valine in order to inhibit methionine biosynthesis (Van Duyne et al., 1993) . The SeMet-substituted enzyme was active and was puri®ed by the same protocol as the wild-type enzyme. Approximately 50 mg of puri®ed protein was obtained from a 2 l culture broth. Incorporation of selenomethionine was veri®ed by MALDI mass spectrometry (data not shown). The SeMet protein did not crystallize de novo, but native PMM/PGM crystals were successfully used to seed into SeMet PMM/PGM drops containing the crystallization buffer described above plus 1.0 mM -mercaptoethanol. SeMet protein concentration was 6 mg ml À1 for seeding. Small de novo SeMet crystals produced from seeding with native crystals were used as seeds to grow larger SeMet PMM/PGM crystals for data collection.
The SeMet PMM/PGM crystallizes isomorphously with the native enzyme. Although the SeMet PMM/PGM crystals are quite sensitive to radiation damage at room temperature (lifetime on rotating anode <1 h), the cryoprotectant used for the native crystals is also suitable for the SeMet crystals and extends crystal lifetime in the beam inde®nitely. Presumably because of their smaller size, the SeMet PMM/PGM crystals diffract to a nominal resolution of 2.2 A Ê on a synchrotron X-ray source.
Results and discussion
A native data set to 1.75 A Ê for PMM/PGM was collected from a single crystal on beamline X8C at Brookhaven National Laboratory (Table 1; Fig. 2 ). Data were collected at approximately 100 K using the cryoprotectant described above. The X-ray wavelength was 0.98 A Ê , the oscillation angle was 0.75 and the crystal-to-detector distance was 130 mm. Crystals belong to space group P2 1 2 1 2 1 and have unit-cell parameters a = 70.89, b = 73.02, c = 92.57 A Ê , = = = 90 . Data were processed using DENZO and SCALEPACK (Otwinowski & Minor, 1997) . Packing density calculations for PMM/PGM indicate V m = 2.43 A Ê 3 Da À1 , assuming one molecule of PMM/PGM per asymmetric unit. This corresponds to a solvent fraction of about 49%, a typical value for protein crystals (Matthews, 1968) .
The protein of known structure most closely related to PMM/PGM is PGM from rabbit. Several models derived from rabbit PGM structure were used for molecularreplacement attempts. However, no solution was found, presumably owing to the low sequence identity between the two proteins ($21%). Structure-determination efforts will proceed via the SeMet PMM/PGM crystals that were recently used in MAD experiments at beamline X8C at Brookhaven National Laboratory. Re®nement of PMM/PGM with 1.75 A Ê native data should provide an excellent starting point for studies of enzyme±inhibitor complexes. 
Figure 2
Diffraction pattern of native PMM/PGM crystals at beamline X8C at the National Synchrotron Light Source.
